TD Cowen maintains LuxExperience at Buy, raises price target to $12 from $11

TD Cowen reaffirmed its Buy rating for LuxExperience and increased its price target to $12 from $11, suggesting a 14.9% upside from the Nov 10 close of $10.44. The new target represents a 9.1% increase.

Original reporting
Published Nov 11, 2026, 4:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 4:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Cowen maintains LuxExperience at Buy, raises price target to $12 from $11 — source image
Decision brief

The 30-second read

Med
01

Why it matters

The rating lift suggests short‑term buying interest but the small absolute target change limits upside potential.

02

Market read

A modest analyst upgrade for a low‑cap stock; limited broader market relevance.

03

What to watch

Liquidity constraints and limited analyst coverage could mute price response.

Relevance 5/10Novelty 6/10Timing: today

Background

TD Cowen raised its price target for LuxExperience from $11 to $12, implying a modest upside.

Market effects

Limited impact; rating change affects only the micro‑cap niche of experiential travel.

No broader regional effect.

Minimal.

Counterpoint

The upgrade may be premature if the company's growth outlook is over‑optimistic.

Key entities

  • LuxExperience

    Micro‑cap experiential travel firm covered by TD Cowen.

Related articles

MedAI 8/10

LuxExperience Q1 FY27 slides: all segments accelerate growth

LuxExperience reported Q1 FY27 results with 8.5% constant-currency net sales growth to €610.5M and improved adjusted EBITDA margin to 2.1%. All segments grew, with Mytheresa leading at 10.0% sales growth. The stock surged 6.98% premarket to $11.50. The company raised full-year guidance, citing strong customer metrics and cost management.

$LUXEHigh

LuxExperience B.V. (LUXE): Financial results for Q1 2027

LuxExperience B.V. (LUXE) furnished an SEC Form 6-K — earnings release. Exhibit 99.2 Q1 FY27 Results: LuxExperience with strong Net Sales growth of +8.5% ex-FX (+9.6% reported) and significantly improved Adjusted EBITDA profitability across all three segments in Q1 FY27 vs. Q1 FY26; Raising FY27 guidance KEY HIGHLIGHTS · LuxExperience 1 with strong t

$LUXEMedAI 9/10

Q1 FY27 Results: LuxExperience with strong Net Sales growth of +8.5% ex-FX (+9.6% reported) and significantly improved Adjusted EBITDA profitability across all three segments in Q1 FY27 vs. Q1 FY26; Raising FY27 guidance

LuxExperience (LUXE) reported Q1 FY27 net sales of €610.5M, up 9.6% (8.5% ex-FX) YoY. Adjusted EBITDA improved to €12.7M (2.1% margin) from a loss a year earlier. The company raised its FY27 Adjusted EBITDA margin guidance to 2.5-3.5%.

Med

LuxExperience posts €167.7M loss on €2.5B sales

LuxExperience B.V. reported fiscal 2026 net sales of €2.5B and a net loss of €167.7M, with a continuing-operations loss of €157.2M. Mytheresa's net sales rose 8.5% to €994.3M, while YOOX's sales fell 8.4% to €485.1M. The company completed the sale of THE OUTNET assets in April 2026 and will hold its AGM on November 5, 2026.

MedAI 8/10

LuxExperience B.V. Q4 2026 Earnings Call Summary

LuxExperience B.V. reported Q4 2026 earnings, highlighting EBITDA break-even 15 months post-acquisition. Mytheresa reached EUR 1 billion in sales, while NET-A-PORTER and MR PORTER returned to growth. YOOX cut losses by half. Management expects 2%-3% EBITDA margins in FY 2027 and EUR 4 billion in net sales by 2028. The company improved operational efficiency and strengthened its financial position.

$LUXEMed

Luxe (LUXE) Q4 2026 Earnings Call Transcript

Luxe (LUXE) reported Q4 2026 net sales of EUR 663.8M, up 18.7% YoY, and full-year sales of EUR 2.5B, up 104.1% due to acquisitions. Adjusted EBITDA was EUR 13.6M with a 2.1% margin. Mytheresa grew 10.2% with strong U.S. performance, while NET-A-PORTER and MR PORTER saw 5.6% growth. YOOX grew 6.6% but remained unprofitable. The company guided for mid to high single-digit sales growth and 2-3% EBITDA margin in 2027, with a $50M share repurchase plan.